Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Analysis
  3. 35 Years of VAERS Reporting
7 min read
Share

35 Years of VAERS Reporting

From 2,214 reports in 1990 to 768,706 in 2021 — and the journey back to baseline.

2,214
1990 (first year)
768,706
2021 (peak)
40,283
2025 (declining)

Three Eras of VAERS

The history of VAERS reporting can be divided into three distinct eras:

Era 1: Early VAERS (1990-2006)

VAERS started small with just 2,214 reports in its first year. Through the 1990s and early 2000s, annual reports hovered around 10,000-18,000. This was a period of steady, predictable growth as the system matured and awareness increased.

Era 2: Growth Period (2007-2019)

Starting around 2007, reporting jumped to 30,000-50,000 per year. Several factors drove this: the introduction of new vaccines (HPV, rotavirus), increased digital reporting infrastructure, and growing public awareness of VAERS. The pre-COVID decade (2010-2019) averaged about 40,051 reports per year.

Era 3: COVID and Beyond (2020-Present)

The COVID-19 vaccination campaign caused an explosive spike in 2021 (768,706 reports). Since then, reporting has declined 95% from the peak. By 2025, annual reports (40,283) are approaching pre-COVID levels, suggesting the system is returning to its historical baseline.

Return to Baseline

The decline from the 2021 peak is significant and expected. As COVID-19 vaccination rates dropped, booster uptake declined, and the heightened awareness of VAERS faded, reports returned toward pre-pandemic levels. This pattern confirms that the spike was driven by the pandemic context, not a permanent change in reporting behavior.

Key Takeaways

  • 1.VAERS has gone from ~2K reports/year to a peak of 769K, reflecting system growth and the COVID spike
  • 2.Post-COVID reporting has declined 95% from the 2021 peak, approaching pre-pandemic levels
  • 3.The return to baseline suggests the spike was context-driven, not a permanent shift

Related Analysis

COVID-19 Impact
Deeper dive into the pandemic era
Top Symptoms
Most commonly reported adverse events